Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway

	Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
Source Publication	Journal of Experimental & Clinical Cancer Research
	2019
Volume	38 Pages:e265
	Jiang L; Wang P; Sun YJ; Wu YJ(伍一军)
Document Type	期刊论文
Identifier	http://ir.ioz.ac.cn/handle/000000/14090
Collection	农业虫害鼠害综合治理研究国家重点实验室
Recommended Citation GB/T 7714	Jiang L,Wang P,Sun YJ,et al. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway[J]. Journal of Experimental & Clinical Cancer Research,2019,38:e265.
APA	Jiang L,Wang P,Sun YJ,&伍一军.(2019).Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.Journal of Experimental & Clinical Cancer Research,38,e265.
MLA	Jiang L,et al."Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway".Journal of Experimental & Clinical Cancer Research 38(2019):e265.

Related Services

Bookmark

Google Scholar

Similar articles in Bing Scholar

Terms of Use

No data!

Social Bookmark/Share

File name:	Ivermectin reverses the drug resistance.pdf
Format:	Adobe PDF

All comments (0)

No comment.

The comment function is only available to registered usersLog In

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Institution:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh

中国科学院动物研究所机构知识库